Table 1 Characteristics of Study Groups
Group | ID | Sex | A01 status | Age at infection, years | Peak PVL | Pre-ART PVL |
|---|---|---|---|---|---|---|
ART | 33955 | Male | + | 4.03 | 5.61×106 | 8.32×105 |
34908 | Male | − | 3.00 | 1.03×107 | 2.65×107 | |
X60 | Female | − | 4.10 | 3.18×107 | 2.99×106 | |
RKa17 | Male | − | 2.98 | 5.23×106 | 6.07×105 | |
RFp17 | Male | − | 2.86 | 9.82×106 | 1.75×106 | |
RGw17 | Male | − | 2.86 | 2.84×107 | 3.54×107 | |
RhmAb | 34934 | Male | + | 3.00 | 1.44×107 | 8.13×105 |
33929 | Male | − | 4.04 | 1.43×107 | 5.94×106 | |
34906 | Male | − | 3.01 | 1.91×107 | 1.07×106 | |
35489 | Female | − | 2.89 | 3.68×107 | 7.57×106 | |
RWg17 | Male | − | 3.83 | 1.95×107 | 7.50×105 | |
RCp17 | Male | − | 2.99 | 4.12×107 | 2.20×107 | |
RhmAb + AZD5582 | 33931 | Male | + | 4.04 | 5.80×107 | 1.43×105 |
34933 | Male | − | 3.00 | 2.36×107 | 1.01×106 | |
33940 | Male | − | 4.04 | 3.38×107 | 4.80×106 | |
34900 | Male | − | 3.19 | 8.19×106 | 4.98×106 | |
33939 | Male | − | 4.54 | 5.31×106 | 3.17×104 | |
33961 | Male | − | 3.96 | 5.12×107 | 3.03×107 | |
34903 | Male | − | 3.18 | 3.62×107 | 1.04×107 | |
34929 | Male | − | 3.42 | 4.60×107 | 1.20×107 | |
33960 | Male | − | 3.87 | 3.80×107 | 2.59×106 | |
RhmAb + AZD5582 + N-803 | RZb18 | Male | − | 2.78 | 2.40×107 | 3.83×106 |
RJu17 | Male | − | 2.88 | 2.72×107 | 4.08×107 | |
RVg18 | Male | − | 2.78 | 6.21×106 | 3.04×105 | |
RWv17 | Male | − | 2.87 | 2.26×107 | 2.24×107 | |
34898 | Male | − | 3.58 | 5.46×107 | 1.28×108 | |
RBo17 | Female | − | 3.59 | 1.85×107 | 1.62×107 | |
RLz17 | Male | − | 2.82 | 2.80×107 | 6.44×105 | |
RJk17 | Female | − | 3.77 | 1.52×107 | 3.32×106 | |
35493 | Female | − | 2.88 | 2.32×107 | 7.36×107 |
